These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26185264)

  • 1. A Patient on Peritoneal Dialysis with Refractory Volume Overload.
    Wilkie M
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):155-60. PubMed ID: 26185264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.
    Davies SJ; Brown EA; Frandsen NE; Rodrigues AS; Rodriguez-Carmona A; Vychytil A; Macnamara E; Ekstrand A; Tranaeus A; Filho JC;
    Kidney Int; 2005 Apr; 67(4):1609-15. PubMed ID: 15780118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
    Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
    Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume control in diabetic and nondiabetic peritoneal dialysis patients.
    Gan HB; Chen MH; Lindholm B; Wang T
    Int Urol Nephrol; 2005; 37(3):575-9. PubMed ID: 16307345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages?
    Kuriyama S
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S190-5. PubMed ID: 17556303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical guidelines for automated peritoneal dialysis.
    Sritippayawan S; Nilwarangkur S; Aiyasanon N; Jattanawanich P; Vasuvattakul S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S167-74. PubMed ID: 22043586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative dialysis strategies with icodextrin.
    Panzer SE; Teitelbaum I
    Contrib Nephrol; 2012; 178():11-15. PubMed ID: 22652709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Icodextrin alone" for initiation of peritoneal dialysis.
    Jeloka TK
    Perit Dial Int; 2008; 28(5):563-4. PubMed ID: 18708559
    [No Abstract]   [Full Text] [Related]  

  • 12. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities.
    Fourtounas C; Hardalias A; Dousdampanis P; Papachristopoulos B; Savidaki E; Vlachojannis JG
    Adv Perit Dial; 2008; 24():27-31. PubMed ID: 18985997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange.
    Davies SJ; Garcia Lopez E; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimburger O; Simonsen O; Davenport A; Lindholm B; Tranaeus A; Divino Filho JC
    Nephrol Dial Transplant; 2008 Sep; 23(9):2982-8. PubMed ID: 18456678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal dialysis in patients with diabetic nephropathy].
    Auinger M; Edlinger R; Prager R
    Wien Klin Wochenschr; 2005; 117 Suppl 6():29-34. PubMed ID: 16437330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
    Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
    Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal use of peritoneal dialysis fluids in type 2 diabetes mellitus patients].
    Ryckelynck JP; Allard C; Cousin M; Hurault de Ligny B; El Haggan W; Lobbedez T
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S82-5. PubMed ID: 17378147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting solute clearance in peritoneal dialysis.
    Krediet RT; Douma CE; van Olden RW; Ho-dac-Pannekeet MM; Struijk DG
    Kidney Int; 1998 Dec; 54(6):2218-25. PubMed ID: 9853288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
    Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
    J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.
    Davies SJ
    Kidney Int; 2004 Dec; 66(6):2437-45. PubMed ID: 15569337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis.
    Morimoto S; Takahashi N; Someya K; Morita T; Jo F; Toyoda N; Kosaki A; Nishikawa M; Iwasaka T
    Clin Exp Nephrol; 2010 Aug; 14(4):363-6. PubMed ID: 20186457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.